AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Reserve excluding Revaluation Reserve History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Reserve excluding Revaluation Reserve | ₹37,833 Cr | ₹32,595 Cr | ₹29,784 Cr | ₹26,781 Cr | ₹24,517 Cr |
What is the latest Reserve excluding Revaluation Reserve ratio of AUROBINDO PHARMA ?
| Year | Reserve excluding Revaluation Reserve |
|---|---|
| Mar2026 | ₹37,833 Cr |
| Mar2025 | ₹32,595 Cr |
| Mar2024 | ₹29,784 Cr |
| Mar2023 | ₹26,781 Cr |
| Mar2022 | ₹24,517 Cr |
How is Reserve excluding Revaluation Reserve of AUROBINDO PHARMA Trending?
| Years | Reserve excluding Revaluation Reserve | % Change | |
|---|---|---|---|
| Mar2026 | ₹37,833 Cr | 16.07 | |
| Mar2025 | ₹32,595 Cr | 9.44 | |
| Mar2024 | ₹29,784 Cr | 11.21 | |
| Mar2023 | ₹26,781 Cr | 9.23 | |
| Mar2022 | ₹24,517 Cr | - | |
Compare Reserve excluding Revaluation Reserve of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹98,807.7 Cr | 3.1% | 6.9% | 57.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | 1.8% | -1.7% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 2.6% | 9.8% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | 2.4% | -0.5% | 36% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 1.8% | -3.7% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 4.5% | 1.8% | -10% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 3.1% |
6.9% |
57.9% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses